ºñ±Þ¿©´ë»óÇ׸ñ
°Ë»ö °Ë»ö

¿øÇϽô ³»¿ªÀ» °Ë»öÇÏ½Ã¸é ±Ý¾×À» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

ºñ±Þ¿© Áø·áºñ
1Â÷ºÐ·ù ó¹æºÐ·ù ¸íĪ ÄÚµå ºñ¿ë ÃÖÀú
ºñ¿ë
ÃÖ´ë
ºñ¿ë
Ä¡·á
Àç·á´ë
Æ÷ÇÔ
¿©ºÎ
¾àÁ¦ºñ
Æ÷ÇÔ
¿©ºÎ
ƯÀÌ
»çÇ×
ÃÖÁ¾
º¯°æÀÏ
ºñ°í
°Ë»ç·á ±â´É°Ë»ç µ¿¸Æ°æÈ­µµ°Ë»ç (PWV) XSEZ868 55,000 23.03.13
°Ë»ç·á ±â´É°Ë»ç Pain Vision(CPT)(ÀÔ¿ø) FY884 30,000 P-OP,°æ°ú
°Ë»ç·á ±â´É°Ë»ç Pain Vision(CPT)(¿Ü·¡) FY884A 30,000 22.09.28
°Ë»ç·á ±â´É°Ë»ç T-wave (¹Ì¼¼ÀüÀ§ T±³´ëÆÄ°Ë»ç) EZ874 70,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸é À§³»½Ã°æÃß°¡(´ëÀ庸ÇèÀû¿ë) BZ128 50,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸é ´ëÀå³»½Ã°æÃß°¡(À§º¸ÇèÀû¿ë) BZ127 60,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸é ¿Ü·¡À§³»½Ã°æ(Ãß°¡)+°ø´Ü´ëÀå BZ126 50,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸é ¿Ü·¡´ëÀå³»½Ã°æ(Ãß°¡)+°ø´ÜÀ§ BZ125 80,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸éÀ§³»½Ã°æ·á BZ119 70,000
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸é´ëÀå³»½Ã°æ·á BZ122 80,000 23.03.13
°Ë»ç·á ³»½Ã°æ°Ë»ç ¼ö¸éÀ§,´ëÀå³»½Ã°æ·á BZ122A 130,000 23.03.13
°Ë»ç·á Áø´Ü°Ë»ç È£Èí±â ¹ÙÀÌ·¯½º PCR[ºñ±Þ¿©] D6802066A 120,000 °í½Ã Á¦2023-160È£(ÇàÀ§)
°Ë»ç·á Áø´Ü°Ë»ç BRAF gene V600E mutation C5831176 150,000 °í½Ã Á¦2018-227È£(ÇàÀ§)
°Ë»ç·á Áø´Ü°Ë»ç HPV genotype(LBMA)/ÀÎÀ¯µÎÁ¾¹ÙÀÌ·¯½º C6031006 80,000 ÀÎÁ¤±âÁØ¿Ü ºñ±Þ¿©
°Ë»ç·á Áø´Ü°Ë»ç ¾×»ó¼¼Æ÷°Ë»ç-ÀÚ±ÃÁú ¼¼Æ÷º´¸®°Ë»ç C5624 60,000 23.03.01
1 2 3 4 5 6 7 8 9 10